Literature DB >> 20673825

Implementing a birth dose of hepatitis B vaccine for home deliveries in Africa--too soon?

Anna Kramvis1, C John Clements.   

Abstract

Despite the recommendation of the World Health Organization (WHO) to provide the first hepatitis B vaccine dose at birth (within 24h), there are epidemiological, economic and logistical reasons why this may not be the best approach for home births in Africa. The WHO policy presupposes that the epidemiology of hepatitis B infection in Africa is similar to the rest of the world and that the organizational, infrastructural and financial support is adequate. While babies born in health facilities may be relatively easy to immunize at birth, health systems and infrastructures in many resource-poor countries in Africa would be severely challenged, if required to reach home deliveries within 24h of birth.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20673825     DOI: 10.1016/j.vaccine.2010.07.042

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Hepatitis B virus epidemiology.

Authors:  Jennifer H MacLachlan; Benjamin C Cowie
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-01       Impact factor: 6.915

2.  A decision analytic model for prevention of hepatitis B virus infection in Sub-Saharan Africa using birth-dose vaccination.

Authors:  Sarah Anderson; Lorie M Harper; Jodie Dionne-Odom; Gregory Halle-Ekane; Alan T N Tita
Journal:  Int J Gynaecol Obstet       Date:  2018-01-31       Impact factor: 3.561

3.  Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants.

Authors:  Charles S Chasela; Athena P Kourtis; Patrick Wall; Jan Drobeniuc; Caroline C King; Hong Thai; Eyasu H Teshale; Mina Hosseinipour; Sascha Ellington; Mary B Codd; Denise J Jamieson; Rod Knight; Patricia Fitzpatrick; Saleem Kamili; Irving Hoffman; Dumbani Kayira; Noel Mumba; Deborah D Kamwendo; Francis Martinson; William Powderly; Chong-Gee Teo; Charles van der Horst
Journal:  J Hepatol       Date:  2013-11-06       Impact factor: 25.083

4.  Hepatitis B vaccination timing: results from demographic health surveys in 47 countries.

Authors:  Aparna Schweitzer; Manas K Akmatov; Gérard Krause
Journal:  Bull World Health Organ       Date:  2017-01-26       Impact factor: 9.408

5.  The innovation of the subspecialty of Paediatric Virology: An interview with Research Professor of Molecular Virology Anna Kramvis.

Authors:  Ioannis N Mammas; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2017-08-23       Impact factor: 2.447

Review 6.  Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks.

Authors:  Patrick T F Kennedy; Samuel Litwin; Grace E Dolman; Antonio Bertoletti; William S Mason
Journal:  Viruses       Date:  2017-04-29       Impact factor: 5.048

7.  The association between maternal hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of hepatitis B e antigenaemia in Gambian children.

Authors:  Yusuke Shimakawa; Christian Bottomley; Ramou Njie; Maimuna Mendy
Journal:  BMC Public Health       Date:  2014-05-30       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.